Cargando…
Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas
Diffuse intrinsic pontine gliomas (DIPG) are an incurable childhood brain cancer for which novel treatments are needed. DIPGs are characterized by a mutation in the H3 histone (H3K27M), resulting in loss of H3K27 methylation and global gene dysregulation. TRX-E-009–1 is a novel anticancer agent with...
Autores principales: | Ehteda, Anahid, Khan, Aaminah, Rajakumar, Gayathiri, Vanniasinghe, Anne S., Gopalakrishnan, Anjana, Liu, Jie, Tsoli, Maria, Ziegler, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690044/ https://www.ncbi.nlm.nih.gov/pubmed/37683275 http://dx.doi.org/10.1158/1535-7163.MCT-23-0179 |
Ejemplares similares
-
DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2020) -
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas
por: Khan, Aaminah, et al.
Publicado: (2021) -
Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma
por: Tsoli, Maria, et al.
Publicado: (2018) -
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
por: Burmeister, Aaron, et al.
Publicado: (2022) -
RARE-08. POTENTIAL NEW THERAPIES FOR DIFFUSE INTRINSIC PONTINE GLIOMAS IDENTIFIED THROUGH HIGH THROUGHPUT DRUG SCREENING
por: Upton, Dannielle, et al.
Publicado: (2021)